|
| 37098064 | Multiple models for outbreak decision support in the face of uncertainty. | Proc Natl Acad Sci U S A | 2023 |
| 36196586 | Leveraging Serosurveillance and Postmortem Surveillance to Quantify the Impact of Coronavirus Disease 2019 in Africa. | Clinical Infectious Diseases | 2023 |
| 36437905 | Impact of SARS-CoV-2 vaccination of children ages 5-11 years on COVID-19 disease burden and resilience to new variants in the United States, November 2021-March 2022: A multi-model study. | Lancet Reg Health Am | 2023 |
| 37738280 | Estimating the time-varying reproduction number for COVID-19 in South Africa during the first four waves using multiple measures of incidence for public and private sectors across four waves. | | 2023 |
| 38090227 | Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa. | Influenza Other Respir Viruses | 2023 |
| 37985664 | Evaluation of the US COVID-19 Scenario Modeling Hub for informing pandemic response under uncertainty. | | 2023 |
| 37976465 | Correction: Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines. | PLoS Med | 2023 |
| 37873362 | Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States. | | 2023 |
| 37873156 | Scenario Design for Infectious Disease Projections: Integrating Concepts from Decision Analysis and Experimental Design. | | 2023 |
| 37216529 | Inferring the differences in incubation-period and generation-interval distributions of the Delta and Omicron variants of SARS-CoV-2. | | 2023 |
| 37461674 | Informing pandemic response in the face of uncertainty. <i>An evaluation of the U.S. COVID-19 Scenario Modeling Hub</i>. | medRxiv | 2023 |
| 36701368 | Global and national influenza-associated hospitalisation rates: Estimates for 40 countries and administrative regions. | | 2023 |
| 36811598 | Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022. | Elife | 2023 |
| 36695018 | Context-dependent representation of within- and between-model uncertainty: aggregating probabilistic predictions in infectious disease epidemiology. | | 2023 |
| 36791146 | Host heterogeneity and epistasis explain punctuated evolution of SARS-CoV-2. | | 2023 |
| 37527470 | Predictors of severity of influenza-related hospitalizations: Results from the Global Influenza Hospital Surveillance Network (GIHSN). | | 2023 |
| 35084450 | Direct and Indirect Effects of the Coronavirus Disease 2019 Pandemic on Private Healthcare Utilization in South Africa, March 2020-September 2021. | Clin Infect Dis | 2022 |
| 35771775 | Projecting the SARS-CoV-2 transition from pandemicity to endemicity: Epidemiological and immunological considerations. | PLoS Pathogens | 2022 |
| 36172128 | Behavioral factors and SARS-CoV-2 transmission heterogeneity within a household cohort in Costa Rica. | Res Sq | 2022 |
| 35968872 | The Use of Death Certificate Data to Characterize Mortality Associated With Respiratory Syncytial Virus, Unspecified Bronchiolitis, and Influenza in the United States, 1999-2018. | Journal of Infectious Diseases | 2022 |
| 36032973 | Rapidly shifting immunologic landscape and severity of SARS-CoV-2 in the Omicron era in South Africa. | medRxiv | 2022 |
| 35932966 | Understanding the rebound of influenza in the post COVID-19 pandemic period holds important clues for epidemiology and control. | International Journal of Infectious Diseases | 2022 |
| 35420897 | Collaborative Hubs: Making the Most of Predictive Epidemic Modeling. | Am J Public Health | 2022 |
| 35611330 | Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants. | | 2022 |
| 35982666 | Estimating the time-varying reproduction number for COVID-19 in South Africa during the first four waves using multiple measures of incidence for public and private sectors across four waves. | medRxiv | 2022 |
| 35982659 | Immune Heterogeneity and Epistasis Explain Punctuated Evolution of SARS-CoV-2. | | 2022 |
| 35726851 | Projected resurgence of COVID-19 in the United States in July-December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccination. | Elife | 2022 |
| 36380354 | Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants. | BMC Medicine | 2022 |
| 36484987 | Trends in Risk Factors and Symptoms Associated With SARS-CoV-2 and Rhinovirus Test Positivity in King County, Washington, June 2020 to July 2022. | JAMA Netw Open | 2022 |
| 36561171 | Local-Scale phylodynamics reveal differential community impact of SARS-CoV-2 in metropolitan US county. | medRxiv | 2022 |
| 35313577 | The impact of COVID-19 non-pharmaceutical interventions on future respiratory syncytial virus transmission in South Africa. | medRxiv | 2022 |
| 35031600 | Model-based evaluation of alternative reactive class closure strategies against COVID-19. | Nature Communications | 2022 |
| 35194617 | Direct and indirect mortality impacts of the COVID-19 pandemic in the US, March 2020-April 2021. | medRxiv | 2022 |
| 35226079 | Mortality Associated With Influenza and Respiratory Syncytial Virus in the US, 1999-2018. | JAMA network open | 2022 |
| 35169816 | Interactions among 17 respiratory pathogens: a cross-sectional study using clinical and community surveillance data. | medRxiv | 2022 |
| 35094868 | Estimates of mortality associated with seasonal influenza for the European Union from the GLaMOR project. | Vaccine | 2022 |
| 35094714 | Investigating vaccine-induced immunity and its effect in mitigating SARS-CoV-2 epidemics in China. | BMC Medicine | 2022 |
| 34710096 | Synergistic interventions to control COVID-19: Mass testing and isolation mitigates reliance on distancing. | PLoS Computational Biology | 2021 |
| 32409826 | Case Fatality Risk of the First Pandemic Wave of Coronavirus Disease 2019 (COVID-19) in China. | Clinical Infectious Diseases | 2021 |
| 33705690 | Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis. | Lancet Global Health,The | 2021 |
| 34126993 | Hospital utilization rates for influenza and RSV: a novel approach and critical assessment. | Population Health Metrics | 2021 |
| 33750783 | Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China. | Nat Commun | 2021 |
| 33962957 | The impact of relaxing interventions on human contact patterns and SARS-CoV-2 transmission in China. | Science advances | 2021 |
| 33907769 | Model-based evaluation of alternative reactive class closure strategies against COVID-19. | | 2021 |
| 33791745 | Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave in Europe and the United States. | medRxiv | 2021 |
| 33895016 | RSV genomic diversity and the development of a globally effective RSV intervention. | Vaccine | 2021 |
| 34158650 | Despite vaccination, China needs non-pharmaceutical interventions to prevent widespread outbreaks of COVID-19 in 2021. | Nature Human Behaviour | 2021 |
| 33571138 | Contact Tracing and the COVID-19 Response in Africa: Best Practices, Key Challenges, and Lessons Learned from Nigeria, Rwanda, South Africa, and Uganda. | American Journal of Tropical Medicine and Hygiene | 2021 |
| 33833243 | Author Correction: Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China. | Nature Communications | 2021 |
| 33564776 | To what extent do we need to rely on non-pharmaceutical interventions while COVID-19 vaccines roll out in 2021? | | 2021 |